{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T20:08:11Z","timestamp":1778962091351,"version":"3.51.4"},"reference-count":17,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100015676","name":"NSW Health Pathology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015676","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.pathol.2026.02.004","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T14:44:41Z","timestamp":1773758681000},"page":"447-451","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical relevance of discordant urine and serum electrophoresis immunofixation cases"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4707-3392","authenticated-orcid":false,"given":"Fakhria","family":"Kakar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming Wei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian Y.S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2026.02.004_bib1","series-title":"Manual of molecular and clinical laboratory immunology","author":"Roshini","year":"2016"},{"key":"10.1016\/j.pathol.2026.02.004_bib2","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.pathol.2026.02.004_bib3","doi-asserted-by":"crossref","DOI":"10.4065\/81.12.1575","article-title":"Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assays","volume":"81","author":"Katzmann","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.pathol.2026.02.004_bib4","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3324\/haematol.2015.126797","article-title":"Comparison of serum-free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma","volume":"101","author":"Dejoie","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2026.02.004_bib5","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1373\/clinchem.2008.117143","article-title":"Identification of amyloidogenic light chains requires the combination of serum-free light chain assay with immunofixation of serum and urine","volume":"55","author":"Palladini","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.pathol.2026.02.004_bib6","first-page":"99","article-title":"Increased urinary free immunoglobulin light chain excretion in patients with multiple sclerosis","volume":"220","author":"Dobson","year":"2010","journal-title":"J Neuro"},{"key":"10.1016\/j.pathol.2026.02.004_bib7","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1016\/S1470-2045(16)30206-6","article-title":"International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma","volume":"17","author":"Kumar","year":"2016","journal-title":"Lancet Oncol"},{"issue":"Pt 3","key":"10.1016\/j.pathol.2026.02.004_bib8","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1258\/acb.2011.011158","article-title":"Recommendations for standardized reporting of protein electrophoresis in Australia and New Zealand","volume":"49","author":"Tate","year":"2012","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.pathol.2026.02.004_bib9","first-page":"23","article-title":"Proposed addendum to 2012 recommendations for standardised reporting of protein electrophoresis in Australia and New Zealand","volume":"40","author":"Tate","year":"2019","journal-title":"Clin Biochem Rev"},{"key":"10.1016\/j.pathol.2026.02.004_bib10","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1515\/cclm.2011.641","article-title":"Urine immunofixation electrophoresis remains important and is complementary to serum free light chain","volume":"49","author":"Levinson","year":"2011","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.pathol.2026.02.004_bib11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/bjh.13156","article-title":"Guidelines on the diagnosis and investigation of AL amyloidosis","volume":"168","author":"Gillmore","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2026.02.004_bib12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1182\/blood-2016-01-629790","article-title":"What is new in diagnosis and management of light chain amyloidosis?","volume":"128","author":"Palladini","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2026.02.004_bib13","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1021\/pr400985k","article-title":"Using mass spectrometry to monitor monoclonal immunoglobulins in patients with a monoclonal gammopathy","volume":"13","author":"Barnidge","year":"2014","journal-title":"J Proteome Res"},{"key":"10.1016\/j.pathol.2026.02.004_bib14","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1182\/blood.2019000671","article-title":"Role of urine immunofixation in the complete response assessment of MM patients other than light-chain-only disease","volume":"133","author":"Lahuerta","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2026.02.004_bib15","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/labmed\/lmac155","article-title":"Urine protein immunofixation electrophoresis: free light chain urine immunofixation electrophoresis is more sensitive than conventional assays for detecting monoclonal light chains and could serve as a marker of minimal residual disease","volume":"54","author":"Singh","year":"2023","journal-title":"Lab Med"},{"key":"10.1016\/j.pathol.2026.02.004_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-206688","article-title":"The importance of screening for serum-free light chains in suspected cases of multiple myeloma and their impact on the kidney","volume":"2014","author":"Talbot","year":"2014","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.pathol.2026.02.004_bib17","doi-asserted-by":"crossref","first-page":"e340","DOI":"10.1016\/S2352-3026(22)00069-2","article-title":"Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study","volume":"9","author":"El-Khoury","year":"2022","journal-title":"Lancet Haematol"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302526004599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302526004599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T19:30:49Z","timestamp":1778959849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302526004599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0031302526004599"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2026.02.004","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical relevance of discordant urine and serum electrophoresis immunofixation cases","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2026.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}